(Q37785380)

English

Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy

scientific article published on December 1, 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

0 references

Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

0 references

1 reference

based on heuristic

inferred from title

Nehmat Houssami

1

object named as

Nehmat Houssami

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Petra Macaskill

2

object named as

Petra Macaskill

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20817513

7 July 2024

6

object named as

Meagan E. Brennan

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20817513

7 July 2024

author name string

Les Irwig

5

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

M. Luke Marinovich

3

0000-0002-3801-8180

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20817513

7 July 2024

J. Michael Dixon

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20817513

7 July 2024

Lawrence J. Solin

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20817513

7 July 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20817513

7 July 2024

publication date

1 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0959804910007537?httpAccept=text/xml

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

https://api.elsevier.com/content/article/PII:S0959804910007537?httpAccept=text/plain

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

3219-3232

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer

1

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

2

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial

3

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial

4

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

6

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Advances in breast conservation therapy

7

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Standard for breast conservation therapy in the management of invasive breast carcinoma

8

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction.

9

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy

10

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

11

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Consensus conference on breast conservation

12

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Margins in breast-conserving therapy: have we lost sight of the big picture?

13

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

The surgical margin status after breast-conserving surgery: discussion of an open issue

14

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Prognostic factors for local control after breast conservation: does margin status still matter?

15

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Role of resection margins in patients treated with breast conservation surgery

16

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey

17

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy

20

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence.

21

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Systematic reviews of evaluations of prognostic variables

22

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy

24

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Negative margin status improves local control in conservatively managed breast cancer patients

25

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer

26

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Results of breast-conserving therapy for early stage breast cancer: Kyoto University experiences.

27

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials

28

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Breast-conserving surgery following radiation therapy of 50 Gy in stages I and II carcinoma of the breast: the experience at one institute in Japan

29

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy

30

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Outcome of breast-conserving therapy in the Tokyo Women's Medical University Breast Cancer Society experience

31

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Conservation therapy in T1-T2 breast cancer: past, current issues, and future challenges and opportunities

32

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Predictors of reexcision findings and recurrence after breast conservation.

33

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Fifteen-year results of breast-conserving surgery and definitive irradiation for Stage I and II breast carcinoma: the University of Pennsylvania experience

34

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial

35

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Treatment outcome of breast-conserving therapy in patients with positive or close resection margins: Japanese multi institute survey for radiation dose effect

36

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Breast conservation surgery achieving>or=2 mm tumor-free margins results in decreased local-regional recurrence rates

37

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

The effect of timing of radiotherapy after breast-conserving surgery in patients with positive or close resection margins, young age, and node-negative disease, with long term follow-up

38

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Breast conserving treatment in Denmark, 1989-1998. A nationwide population-based study of the Danish Breast Cancer Co-operative Group.

39

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up

40

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

The role of radiotherapy in treating small early invasive breast cancer

41

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Recursive partitioning identifies patients at high and low risk for ipsilateral tumor recurrence after breast-conserving surgery and radiation

42

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy

43

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy

44

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Improving local control with breast-conserving therapy: a 27-year single-institution experience

45

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Surgical margin and breast recurrence after breast-conserving therapy

46

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed.

47

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

The importance of the lumpectomy surgical margin status in long-term results of breast conservation

48

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer

49

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: the University of Pennsylvania experience

50

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer

51

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Risk factors in breast-conservation therapy.

52

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Influence of radiation dose on positive surgical margins in women undergoing breast conservation therapy

54

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Lumpectomy margins, reexcision, and local recurrence of breast cancer

55

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

The importance of the resection margin in conservative surgery for breast cancer

56

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy

57

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial

58

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Importance of margin status in outcome of breast-conserving surgery for carcinoma

59

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Clinical outcome of breast conservation therapy for breast cancer in Hong Kong: prognostic impact of ipsilateral breast tumor recurrence and 2005 St. Gallen risk categories

60

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first.

61

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

The impact of margin status on local recurrence following breast conserving therapy for invasive carcinoma in Manitoba

62

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Eight-year results of a prospective non-randomised study on therapy of small breast cancer. The German Breast Cancer Study Group (GBSG)

63

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial

64

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Ipsilateral breast tumor relapse after breast conserving surgery in women with breast cancer.

65

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel

66

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98

67

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

68

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

69

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

70

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Multicentricity of breast carcinoma demonstrated by routine correlated serial subgross and radiographic examination

71

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery

72

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution

73

1 reference

10.1016/J.EJCA.2010.07.043

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.043

7 July 2024

Identifiers

10.1016/J.EJCA.2010.07.043

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37785380&oldid=2197240673"